We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS Guidance Requires Drugmakers to Pay Up if Price Hikes Exceed Inflation Rate
CMS Guidance Requires Drugmakers to Pay Up if Price Hikes Exceed Inflation Rate
Newly released federal guidance details how the federal government will punish drug companies that hike prices faster than the rate of inflation for some prescription Medicare medicines — a move some lawmakers view as long overdue.